COST EFFECTIVENESS ANALYSIS (CEA) PENGGUNAAN GOLONGAN OBAT NEUROPROTEKTAN CITICOLINE INJEKSI DAN PIRACETAM INJEKSI PADA PASIEN STROKE DI RSU IMELDA PEKERJA INDONESIA MEDAN

  • Alex Sinaga Universitas Imelda Medan
  • Agni Anjani Universitas Imelda Medan
Keywords: Cost Effectiveness Analysis, Citicoline Injeksi, Piracetam Injeksi, Stroke

Abstract

Stroke is disease or functional disorder of the brain in the form of nerve paralysis (neurological deficit) due to obstruction of blood flow to the brain. One of the therapies given to stroke patients is by giving neuroprotectant drugs, namely citicoline injection and piracetam injection. The purpose of this study was to determine the effectiveness of therapy and cost effectiveness of stroke patients' therapy between the use of alternative citicoline injection and injection piracetam in a pharmacoeconomic manner with a Cost Effectiveness approach in RSU Imelda Pekerja Indonesia Medan. This study uses a retrospective Cohort Study method. The sample of this study consisted of 44 patients, namely 22 patients treated with citicoline injection and 22 patients treated with piracetam injection. The results of this study were obtained from the comparison of ACER (Average Cost Effectiveness Ratio) and ICER (Incremental Cost Effectiveness Ratio) values. The ACER value of citicoline injection is Rp. 11.949.- less than the ACER value of piracetam Rp. 15.474.- so that the Cost Effective ACER value which has the lowest ACER value is citicoline injection. The ICER value of the comparison of citicoline injection and injection piracetam is Rp. -32.661.- . which means the ICER result is negative or getting smaller, it is considered more effective and cheaper, in accordance with quadrant II the plant's cost-effectiveness decreases so that the neuroprotectant drug class therapy with the most Cost Effectiveness of stroke patients in RSU Imelda Pekerja Indonesian Medan is citicoline injection.

References

Adibhatla, R. M., Hatcher, J. F., 2005, Cytidine 5- Diphosphocholine (CDP-choline) in Stroke and other CNS disorder, Journal Neurochemistry Res., 70: 133-139.

Baroroh, F, Fauzi LA. Analisis biaya terapi stroke pada pasien rawat inap di rumah sakit PKU muhammadiyah bantul yogyakarta. J ilmu ibnu sina. 2017;2(1):93-101.

Davalos A., J. Castillo, Jose A. S., Julio J. S., Joan M., Sonia L., dkk. 2002, Oral Citicoline in Acute IschemicStroke: An Individual Patient Data Pooling Analysis Of Clinical Trials, Journal of American Heart Assosiation, 33:2850–2857.

Grosse D.S.,Teutsch M.S. Developing, Implementing and Population Intervention. Genetics and Prevention Effectiveness. Genetics and Public Health in 21st Century: Oxford University Press 2000.

Hauer A.J., Ynte M.R., Ale A., Ewoud J.van D., Peter J.K., Gert-Jan L., Paul J.N., Robert J.van O., Marieke C.V., Marieke J.W., L. Jaap K. and Catharina J.M., 2017, Age-Specific Vascular Risk Factor Profiles According to Stroke Subtype, Journal of the American Heart Association.

Junaidi, Iskandar (2004). Panduan Parktis Pencegahan Dan Pengobatan Stroke. Jakarta: Pt Bhuana Ilmu Popular.

Kementrian Kesehatan Republik Indonesia Riset Kesehatan Dasar (Riskesdas,2018). Https://Kesmas.Kemkes.Go.Id/Assets/Upload/Dir_519d41d8cd98f00/Files/Hasil-Riskesdas-2018_1274.Pdf. Diakses: 11 Februari 2018
Lisabeth L, Bushel C. (2012). Stroke Risk in Women: The Role of Menopouse and Hormone Therapy. Lancet Neurology, 11, 82-91. http://doi.org/10.1016/S1474-4422(11)70269-1.

Praja. S. D. Hasmono. D. Syifa. N. (2013) Studi Penggunaan Obat Neuroprotektan Pada Pasien Stroke Iskemik. Pharmacy; ISSN: 1693-3591. 10(2): 147-149
Refasi., L.N. Lolo., A.W. Bodhi.,W. (2018). Analisis Efektivitas Biaya (Cost Effectiveness Analysis) Pada Pengobatan Pasien Malaria Falciparum Di Rsud Nabire, Pharmacon; Issn: 2302- 2493.7(2):1-9.

Silalahi. B. (2017) Gambaran Faktor-Faktor Yang Mempengaruhi Terjadinya Stroke Pada Dewasa Dini Di Rumah Sakit X Kota Mesan. Jurnal Ilmiah Keperawatan Imelda: 331-334.

Tri Murti, A. 2013. Farmakoekonomi Prinsip dan Metodologi. Bursa Ilmu, Jogyakarta.

Watila MM, Nyandaiti YW, Bwala SA, Ibrahim A. (2010). Gender Variation Risk Factors and Clinical Presentation of Acute Stroke, Northeastern Nigeria. Journal of Neuroscienceanda Behavioural Health, 3(3), 38-43
Published
2022-03-31